Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL.
Kana MiyazakiRika SakaiNoriko IwakiGo YamamotoKayoko MurayamaMomoko NishikoriKazutaka SunamiIsao YoshidaHiroki YanoNaoki TakahashiAkinao OkamotoSaori MunemotoAiko SawazakiYouko SuehiroNoriko FukuharaAtsushi WakeAyako AraiYasufumi MasakiKohtaro ToyamaAkihiro YokoyamaHiroko TsunemineYuichi HasegawaKenji MatsumotoTomomi YamadaYuki NishimuraSatoshi TamaruNaoko AsanoKohta MiyawakiKoji IzutsuTomohiro KinoshitaRitsuro SuzukiKoichi OhshimaKoji KatoNaoyuki KatayamaMotoko YamaguchiPublished in: Cancer science (2023)